Leishmaniasis is a neglected tropical disease caused by a parasite that is spread by the bite of infected sand flies. It affects millions of people worldwide, mostly in remote areas with poor access to healthcare. Leishmaniasis manifests in different forms, ranging from cutaneous (skin) to visceral (internal organs) and mucocutaneous (mouth and nose) forms.

The disease can be difficult to diagnose as its symptoms, such as fever, weight loss, and swelling of the spleen and liver, can be similar to other diseases. Moreover, treatment is hindered by the limited availability and high cost of drugs.

There are several risk factors for contracting leishmaniasis, including poverty, malnutrition, and weak immune systems. Therefore, prevention efforts should focus on improving basic living conditions such as access to clean water and housing, and raising awareness of the disease.

Leishmaniasis is not only a public health issue but also a social and economic problem, affecting people’s livelihoods and well-being. It is crucial to invest in research and development of new drugs and diagnostic tools, as well as strengthening health systems to provide effective and equitable care for all those affected.